Literature DB >> 19966814

Molecular mechanisms of Escherichia coli pathogenicity.

Matthew A Croxen1, B Brett Finlay.   

Abstract

Escherichia coli is a remarkable and diverse organism. This normally harmless commensal needs only to acquire a combination of mobile genetic elements to become a highly adapted pathogen capable of causing a range of diseases, from gastroenteritis to extraintestinal infections of the urinary tract, bloodstream and central nervous system. The worldwide burden of these diseases is staggering, with hundreds of millions of people affected annually. Eight E. coli pathovars have been well characterized, and each uses a large arsenal of virulence factors to subvert host cellular functions to potentiate its virulence. In this Review, we focus on the recent advances in our understanding of the different pathogenic mechanisms that are used by various E. coli pathovars and how they cause disease in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19966814     DOI: 10.1038/nrmicro2265

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  144 in total

1.  Shiga toxin induces tubular membrane invaginations for its uptake into cells.

Authors:  Winfried Römer; Ludwig Berland; Valérie Chambon; Katharina Gaus; Barbara Windschiegl; Danièle Tenza; Mohamed R E Aly; Vincent Fraisier; Jean-Claude Florent; David Perrais; Christophe Lamaze; Graça Raposo; Claudia Steinem; Pierre Sens; Patricia Bassereau; Ludger Johannes
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

2.  Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation.

Authors:  Bettina Bommarius; David Maxwell; Alyson Swimm; Sara Leung; Anita Corbett; William Bornmann; Daniel Kalman
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

3.  Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-kappaB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells.

Authors:  Alain P Gobert; Marjolaine Vareille; Anne-Lise Glasser; Thomas Hindré; Thibaut de Sablet; Christine Martin
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

4.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

5.  Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

6.  The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.

Authors:  Kim Hodges; Neal M Alto; K Ramaswamy; Pradeep K Dudeja; Gail Hecht
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

7.  Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models.

Authors:  Stephanie Schüller; Yuwen Chong; Jackie Lewin; Brendan Kenny; Gad Frankel; Alan D Phillips
Journal:  Cell Microbiol       Date:  2007-05       Impact factor: 3.715

8.  Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection.

Authors:  Indira U Mysorekar; Megan Isaacson-Schmid; Jennifer N Walker; Jason C Mills; Scott J Hultgren
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

9.  Phosphorylation of the enteropathogenic E. coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation.

Authors:  Neil Phillips; Richard D Hayward; Vassilis Koronakis
Journal:  Nat Cell Biol       Date:  2004-06-27       Impact factor: 28.824

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  339 in total

1.  Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Authors:  Wanyin Deng; Hong B Yu; Carmen L de Hoog; Nikolay Stoynov; Yuling Li; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2012-06-01       Impact factor: 5.911

Review 2.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

3.  Occurrence of Antimicrobial-Resistant Escherichia coli and Salmonella enterica in the Beef Cattle Production and Processing Continuum.

Authors:  John W Schmidt; Getahun E Agga; Joseph M Bosilevac; Dayna M Brichta-Harhay; Steven D Shackelford; Rong Wang; Tommy L Wheeler; Terrance M Arthur
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

4.  Retrospective application of transposon-directed insertion site sequencing to a library of signature-tagged mini-Tn5Km2 mutants of Escherichia coli O157:H7 screened in cattle.

Authors:  Sabine E Eckert; Francis Dziva; Roy R Chaudhuri; Gemma C Langridge; Daniel J Turner; Derek J Pickard; Duncan J Maskell; Nicholas R Thomson; Mark P Stevens
Journal:  J Bacteriol       Date:  2011-01-28       Impact factor: 3.490

Review 5.  Bacteria and host interactions in the gut epithelial barrier.

Authors:  Hiroshi Ashida; Michinaga Ogawa; Minsoo Kim; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

6.  Analyzing of expression of novel polypeptide complexes consisting of Shiga toxin B subunit and Adherence Fimbriae of Escherichia coli based on in silico modeling.

Authors:  Zeinab Noroozian; Mana Oloomi; Saeid Bouzari
Journal:  J Mol Model       Date:  2012-04-24       Impact factor: 1.810

7.  Structural insights into the biogenesis and biofilm formation by the Escherichia coli common pilus.

Authors:  James A Garnett; Verónica I Martínez-Santos; Zeus Saldaña; Tillmann Pape; William Hawthorne; Jennifer Chan; Peter J Simpson; Ernesto Cota; José L Puente; Jorge A Girón; Steve Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

8.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

9.  Deciphering the roles of outer membrane protein A extracellular loops in the pathogenesis of Escherichia coli K1 meningitis.

Authors:  Rahul Mittal; Subramanian Krishnan; Ignacio Gonzalez-Gomez; Nemani V Prasadarao
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

10.  Distribution of strain type and antimicrobial susceptibility of Escherichia coli isolates causing meningitis in a large urban setting in Brazil.

Authors:  Hillary Berman; Maria Goreth Barberino; Edson Duarte Moreira; Lee Riley; Joice N Reis
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.